Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Rectal Cancer
NCT06728982Phase 3Completed
- Sponsor
- Minia University
- Start
- May 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in rectal cancer, sponsored by Minia University. Started May 2024; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT06728982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06728982.